Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)

出版年份 2017 全文链接

标题

作者

关键词

出版物

Volume 16, Issue 11, Pages 2351-2363

出版商

American Association for Cancer Research (AACR)

发表日期

2017-09-23

DOI

10.1158/1535-7163.mct-17-0456

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now